| Thymidine kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker KK Jagarlamudi, M Shaw Biomarkers in medicine 12 (9), 1035-1048, 2018 | 75 | 2018 |
| Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood … KK Jagarlamudi, LO Hansson, S Eriksson BMC cancer 15, 1-12, 2015 | 60 | 2015 |
| Quaternary structures of recombinant, cellular, and serum forms of Thymidine Kinase 1 from dogs and humans S Hanan, KK Jagarlamudi, W Liya, H Ellen, E Staffan BMC biochemistry 13, 1-10, 2012 | 29 | 2012 |
| A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease SE J. Kiran Kumar, A. C. Aronsson, G. Pilko, M. Zupan, K. Kumer, T. Fabjan ... Tumor biology, 2016 | 27 | 2016 |
| High levels of inactive thymidine kinase 1 polypeptide detected in sera from dogs with solid tumours by immunoaffinity methods: implications for in vitro diagnostics J Kiran Kumar, H Sharif, S Westberg, H Von Euler, S Eriksson The Veterinary Journal 197 (3), 2013 | 25 | 2013 |
| Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a … ES Jagarlamudi K, Westberg S, Rönnberg H BMC Veterinary Research 10 ((1): 228), 2014 | 19 | 2014 |
| A New Sandwich ELISA for Quantification of Thymidine Kinase 1 Protein Levels in Sera from Dogs with Different Malignancies Can Aid in Disease Management ES Jagarlamudi KK, Moreau L, Westberg S, Rönnberg H Plos One, 1-15, 2015 | 16* | 2015 |
| AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays JK Kumar, S Holmgren, KH Levedahl, M Höglund, P Venge, S Eriksson Biotechniques 68 (6), 334-341, 2020 | 12 | 2020 |
| The combination of AroCell TK 210 ELISA with Prostate Health Index or prostate‐specific antigen density can improve the ability to differentiate prostate cancer from … KK Jagarlamudi, M Zupan, K Kumer, T Fabjan, G Hlebič, S Eriksson, ... The Prostate 79 (8), 856-863, 2019 | 12 | 2019 |
| Serum TK1 protein and C-reactive protein correlate to treatment response and predict survival in dogs with hematologic malignancies S Saellström, H Sharif, KK Jagarlamudi, H Rönnberg, L Wang, S Eriksson Research in Veterinary Science 145, 213-221, 2022 | 7 | 2022 |
| Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer PO Lundgren, B Tribukait, A Kjellman, U Norming, K Jagarlmudi, ... The Prostate 82 (8), 911-916, 2022 | 5 | 2022 |
| Doxorubicin effects on leukemia and breast cancer cells in culture on the TK1 protein levels using AroCell TK 210 ELISA: a tool for drug development KK Jagarlamudi, L Wang, S Eriksson Nucleosides, Nucleotides and Nucleic Acids 37 (12), 679-686, 2018 | 5 | 2018 |
| A Dual Biomarker TK1 Protein and CA125 or HE4-Based Algorithm as a Better Diagnostic Tool than ROMA Index in Early Detection of Ovarian Cancer D Cviič, K Jagarlamudi, L Meglič, E Škof, A Zore, D Lukanović, S Eriksson, ... Cancers 15 (5), 1593, 2023 | 4 | 2023 |
| Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples KK Jagarlamudi, V P, E S Plos one 17 (10), e0275444, 2022 | 4 | 2022 |
| Quaternary structures of recombinant, cellular, and serum forms of Thymidine kinase 1 from dogs and humans. H Sharif, JK Kumar, L Wang, E He, S Eriksson | 4 | 2012 |
| Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer B Tribukait, PO Lundgren, A Kjellman, U Norming, CR Nyman, ... International Journal of Molecular Sciences 24 (6), 5160, 2023 | 3 | 2023 |
| Serum concentration of thymidine kinase 1 (TK1) as a tumor marker in soft tissue sarcomas S Jaamaa, R Nevala, K Jagarlamudi, E Tukiainen, C Blomqvist, M Sampo Anticancer Research 42 (3), 1509-1515, 2022 | 2 | 2022 |
| Quantitation of cell loss in breast cancer during neoadjuvant treatment (NACT) assessed by serum thymidine kinase protein concentration (sTK1) B Tribukait, KK Jagarlamudi, J Bergh, T Hatschek Annals of Oncology 28, x22, 2017 | 2 | 2017 |
| The Prognostic value of serum TK1 protein determinations using AroCell TK210 ELISA in DLBCL patients treated with R CHOP K Jagarlamudi, G Hedström, P Venge, S Eriksson, D Molin, G Enblad Cancer Research 84 (6_Supplement), 5210-5210, 2024 | | 2024 |
| Determination of canine tk1 protein levels S Eriksson, H Rönnberg, KK Jagarlamudi US Patent App. 18/328,056, 2024 | | 2024 |
Henrik RönnbergProfessor Internal Medicine In Companion Animals, Swedish Univ of Agricultural SciAdresse e-mail validée de slu.se
